NICE issues new guidelines on RitalinBMJ 2000; 321 doi: http://dx.doi.org/10.1136/bmj.321.7269.1100 (Published 04 November 2000) Cite this as: BMJ 2000;321:1100
- Roger Dobson
New guidelines from the National Institute for Clinical Excellence (NICE) for the use of methylphenidate in England and Wales advise that the drug should be used as part of a comprehensive treatment programme for children with a diagnosis of severe attention deficit hyperactivity disorder.
In its latest guidance, the institute said that an estimated 1% of school aged children—69 000 children aged 6 to 16 in England and 4200 in Wales—meet the diagnostic criteria for severe, “combined-type” attention deficit …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial